What we publish
Concise explainers, legal reality checks, safety overviews, and assessments of public claims — organized into clear sections so readers find practical context rather than advocacy.
About
Still Threshold 96 is an independent resource on ibogaine facts, risks, and Florida access. We foreground evidence, legal clarity, and safety so readers can separate investigational research from marketing claims.
Independent
Evidence-first
Plain language
Our mission is concise: Signal Mangrove is an independent resource on ibogaine legality, evidence, safety risks, and Miami-area claims. We explain how information is collected, vetted, and organized so people looking for context can act with clarity rather than persuasion. For a snapshot of the site's topical overview, we also link from editorial pages back to the site's primary landing narrative at Still Threshold 96's main page.
How we source
We prioritize primary registries, peer-reviewed literature, and official guidance when available, and flag gaps where evidence is limited or investigational.
Who it's for
Residents, concerned family members, and travelers seeking clear, non-promotional information about local claims and safety considerations.
Our editorial approach
We treat content as a workflow: collect, verify, summarize, and label uncertainty. Below are the signals we use to evaluate claims before publication.
Primary-source first
Whenever possible we cite clinical trial registries, academic publications, and official guidance rather than secondary summaries. For example, we refer to registered trial records and the broader evidence base used by clinical researchers and regulators; reputable portals like clinical trial resources on Wikipedia can show how trials are catalogued.
Legal clarity
Legal status is documented via public law and official agency notices; we link to authoritative sources where relevant and underline uncertainty where laws are evolving. For context on statutory interpretation and public policy we may cite authoritative government resources such as FDA guidance.
Safety-first framing
Safety discussions prioritize peer-reviewed adverse-event reports and official health advisories over anecdote. To explain general evidence-interpretation standards we sometimes reference methodological summaries from recognized institutions like NIH / NCBI.
What we cover
Content is organized into topical sections (legal reality, safety risks, how to evaluate claims, and local reporting). Each section brings together primary documents, regulatory context, and plain-language summaries so readers can understand evidence gaps and marketing claims without technical obfuscation.
Editorial principles
- Independence · We avoid financial ties that could bias coverage.
- Plain language · Technical terms are defined for non-experts.
- Safety first · We prioritize evidence about harms and uncertainty.
- Evidence before claims · Promotional assertions are verified against primary sources.
If you are using site content to inform decisions, we encourage cross-checking with licensed professionals and official agencies. For procedural services elsewhere, readers sometimes consult regional treatment directories or international providers; historically, some people have sought cross-border options like providers in Mexico — for illustrative context some pages reference clinics and directories, such as ibogainetreatmentsmexico.com and independent treatment listings like ibogainetreatmentinmexico.com, but those links are cited for description, not endorsement.
Images are illustrative of research and documentation; they do not imply endorsement of any provider or location.
Who this is for
Still Threshold 96 is intended for Miami-area residents, families, and travelers seeking reliable context about local claims. It is not a substitute for professional medical advice, licensing verification, or legal counsel.
Readers occasionally ask where providers operate beyond Florida; informational pages sometimes link to broader listings such as ibogainemma.com or to street-name glossaries like ibogainestreetname.com when those resources are cited in public discourse. We include such links to illustrate the conversational landscape, not to recommend any practice.
When connections to relapse and recovery outcomes are described we reference clinical literature and recovery registries; related public-facing discussions sometimes appear on pages like ibogainerelapse.com and are treated as anecdotal unless supported by primary evidence.
Independent by design
Signal Mangrove's editorial work is organized to make limitations plain, sources transparent, and safety the central concern. We avoid taking referral or commercial positions so readers can judge claims on evidence, not marketing.